logo

For the Inventor, By the Inventor

Macclesfield, United Kingdom

Janet Elizabeth Pease

This inventor holds 9 USPTO granted patents. Top assignee: Astrazeneca Ab. Active years: 2003-2009.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Janet Elizabeth Pease. Retrieved from https://idiyas.com/inventor/janet-elizabeth-pease

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 9

Average Co-Inventor Count = 3.6

ph-index = 5

Forward Citations = 342(Granted Patents)


Location History:

  • Macclesfield Cheshire, GB (2004)
  • Macclesfiled, GB (2007)
  • Macclesfield, GB (2003 - 2009)

Company Filing History:

goldMedal9 out of 1,534 
 
Astrazeneca Ab
 patents

Years Active: 2003-2009

Loading Chart...
9 patents (USPTO):Explore Patents
1. 7632840 - Quinazoline compounds for the treatment of hyperproliferative disorders (2009-12-15),
2. 7176212 - 2,4-diamino pyrimidine compounds having anti-cell proliferative activity (2007-02-13),
3. 6878712 - Amides as inhibitors for pyruvate dehydrogenase (2005-04-12),
4. 6716831 - 2,4-diamino-pyrimidine deprivatives having anti-cell proliferative activity (2004-04-06),
5. 6689909 - Substituted N-phenyl 2-hydroxy-2-methyl-3,3,3-trifluoropropanamide derivatives which elevate pyruvate dehydrogenase activity (2004-02-10),
6. 6670368 - Pyrimidine compounds with pharmaceutical activity (2003-12-30),
7. 6632820 - Pyrimidine compounds (2003-10-14),
8. 6593326 - 2,4-diamino pyrimidine compounds having anti-cell proliferative activity (2003-07-15),
9. 6552225 - Chemical compounds (2003-04-22),

Title: Janet Elizabeth Pease: Innovator in Pharmaceutical Chemistry

Introduction

Janet Elizabeth Pease is a distinguished inventor based in Macclesfield, GB. She has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds for the treatment of hyperproliferative disorders. With a total of nine patents to her name, her work has had a profound impact on medical science.

Latest Patents

Among her latest patents, Janet has developed quinazoline compounds aimed at treating hyperproliferative disorders, including cancer. These compounds are characterized by a specific formula that includes various substituents, making them effective as medicaments. Additionally, she has patented 2,4-diamino pyrimidine compounds that exhibit anti-cell proliferative activity. These pyrimidine derivatives are designed to be useful as anti-cancer agents, showcasing her commitment to advancing cancer treatment.

Career Highlights

Janet Elizabeth Pease is currently associated with AstraZeneca AB, a leading global biopharmaceutical company. Her role at AstraZeneca has allowed her to work on groundbreaking research and development projects that aim to improve patient outcomes through innovative therapies.

Collaborations

Throughout her career, Janet has collaborated with notable colleagues, including Gloria Anne Breault and Roger John Butlin. These partnerships have fostered a collaborative environment that enhances the research and development process.

Conclusion

Janet Elizabeth Pease is a remarkable inventor whose work in pharmaceutical chemistry continues to influence the treatment of serious medical conditions. Her innovative patents and collaborations reflect her dedication to improving healthcare through scientific advancements.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…